お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、黄熱病ワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に黄熱病ワクチン市場を分類しています。
本レポートでは世界の黄熱病ワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Sanofi Pasteur、Bio-Manguinhos、FSUE Chumakov、Institut Pasteur de Dakar

レポートは黄熱病ワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。黄熱病ワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Institonal Contributions
    Private Purchase
    Others

用途別の市場セグメント：
    Routine Immunization
    Travelers
    Other

本レポートの詳細内容
本レポートは、世界の黄熱病ワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて黄熱病ワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の黄熱病ワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、黄熱病ワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの黄熱病ワクチン売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の黄熱病ワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本黄熱病ワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：黄熱病ワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 黄熱病ワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける黄熱病ワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章黄熱病ワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：黄熱病ワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：黄熱病ワクチンの主要メーカーの概要を提供し、製品の説明と仕様、黄熱病ワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：黄熱病ワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Yellow Fever Vaccines market is projected to grow from US$ 145 million in 2025 to US$ 186 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
Yellow fever vaccine is a vaccine that can prevent yellow fever. The vaccination targets are people who enter or pass through the epidemic area.
The global Yellow Fever Vaccines market is primarily driven by the increasing risk of yellow fever outbreaks, particularly in endemic regions such as sub-Saharan Africa and parts of South America. Growing international travel and global mobility have heightened the need for preventive vaccination, especially in travelers visiting high-risk areas. Government-led immunization programs and World Health Organization (WHO) initiatives, such as the Eliminate Yellow Fever Epidemics (EYE) strategy, also contribute to increased vaccine demand. Moreover, rising public health awareness and emergency stockpiling by international health agencies are enhancing market growth, with mass vaccination campaigns being conducted to prevent potential epidemics.
Despite the demand, the Yellow Fever Vaccines market faces several significant challenges. Limited global manufacturing capacity can lead to supply shortages during epidemic surges, causing delays in immunization programs. The vaccine requires cold chain logistics and must be stored at controlled temperatures, which poses distribution challenges in low-resource settings. Additionally, adverse reactions to the live-attenuated vaccine—though rare—can affect public perception and vaccination uptake. Regulatory hurdles and the long timeline for clinical trials and approval of newer formulations or alternatives also slow down market expansion, especially as newer manufacturers attempt to enter the space.
Emerging trends in the Yellow Fever Vaccines market include increased public-private partnerships to scale up vaccine production and improve distribution infrastructure. Technological advancements are pushing toward the development of thermostable formulations to overcome cold chain barriers. There is also rising investment in regional vaccine manufacturing hubs, particularly in Africa, to reduce reliance on global supply chains. Enhanced surveillance systems, digital vaccination records, and integration of yellow fever vaccines into routine immunization schedules are improving coverage rates. Moreover, the expansion of travel-related vaccine requirements and efforts to ensure universal access in endemic regions are expected to drive long-term market growth.
Global Yellow Fever Vaccines key players include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, etc. Global top three manufacturers hold a share about 90%. Middle East and Africa is the largest market, with a share about 70%, followed by South America, and Europe, both have a share about 30 percent.  In terms of application, the largest application is Routine Immunization, followed by Travelers.
In terms of consumption side, this report focuses on the sales of Yellow Fever Vaccines by region (region level and country level), by company, by Distribution Channel and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Yellow Fever Vaccines, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
This report researches the key producers of Yellow Fever Vaccines, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Yellow Fever Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Yellow Fever Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Yellow Fever Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Distribution Channel and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Yellow Fever Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar, etc.

Market Segmentation
By Company
    Sanofi Pasteur
    Bio-Manguinhos
    FSUE Chumakov
    Institut Pasteur de Dakar

Segment by Distribution Channel
    Institonal Contributions
    Private Purchase
    Others

Segment by Application
    Routine Immunization
    Travelers
    Other

Production by Region
    Europe
    South America
    Africa

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Distribution Channel, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Yellow Fever Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Yellow Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Distribution Channel, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Distribution Channel, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Distribution Channel, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Distribution Channel, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Distribution Channel, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Distribution Channel, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Yellow Fever Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Yellow Fever Vaccines Market Size Growth Rate by Distribution Channel, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of Institonal Contributions
 Table 3. Major Manufacturers of Private Purchase
 Table 4. Major Manufacturers of Others
 Table 5. Global Yellow Fever Vaccines Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 6. Global Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 7. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 8. Global Revenue Market Share by Region (2020-2031)
 Table 9. Global Yellow Fever Vaccines Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 10. Global Yellow Fever Vaccines Sales by Region (2020-2031) & (K Units)
 Table 11. Global Sales Market Share by Region (2020-2031)
 Table 12. Global Yellow Fever Vaccines Sales by Manufacturers (2020-2025) & (K Units)
 Table 13. Global Yellow Fever Vaccines Sales Share by Manufacturers (2020-2025)
 Table 14. Global Yellow Fever Vaccines Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 15. Global Yellow Fever Vaccines Revenue Market Share by Manufacturers (2020-2025)
 Table 16. Global Key Players of Yellow Fever Vaccines, Industry Ranking, 2023 VS 2024 VS 2024
 Table 17. Yellow Fever Vaccines Price by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Global Yellow Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 19. Global Yellow Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Yellow Fever Vaccines as of 2024)
 Table 20. Global Key Manufacturers of Yellow Fever Vaccines, Manufacturing Base Distribution and Headquarters
 Table 21. Global Key Manufacturers of Yellow Fever Vaccines, Product Offered and Application
 Table 22. Global Key Manufacturers of Yellow Fever Vaccines, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Yellow Fever Vaccines Sales by Distribution Channel (2020-2025) & (K Units)
 Table 25. Global Yellow Fever Vaccines Sales by Distribution Channel (2026-2031) & (K Units)
 Table 26. Global Sales Share by Distribution Channel (2020-2031)
 Table 27. Global Yellow Fever Vaccines Revenue by Distribution Channel (2020-2025) & (US$ Million)
 Table 28. Global Yellow Fever Vaccines Revenue by Distribution Channel (2026-2031) & (US$ Million)
 Table 29. Global Revenue Share by Distribution Channel (2020-2031)
 Table 30. Yellow Fever Vaccines Price by Distribution Channel (2020-2025) & (US$/Unit)
 Table 31. Global Yellow Fever Vaccines Price Forecast by Distribution Channel (2026-2031) & (US$/Unit)
 Table 32. Global Yellow Fever Vaccines Sales by Application (2020-2025) & (K Units)
 Table 33. Global Yellow Fever Vaccines Sales by Application (2026-2031) & (K Units)
 Table 34. Global Sales Share by Application (2020-2031)
 Table 35. Global Yellow Fever Vaccines Revenue by Application (2020-2025) & (US$ Million)
 Table 36. Global Yellow Fever Vaccines Revenue by Application (2026-2031) & (US$ Million)
 Table 37. Global Revenue Share by Application (2020-2031)
 Table 38. Yellow Fever Vaccines Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Yellow Fever Vaccines Price Forecast by Application (2026-2031) & (US$/Unit)
 Table 40. US & Canada Sales by Distribution Channel (2020-2031) & (K Units)
 Table 41. US & Canada Revenue by Distribution Channel (2020-2031) & (US$ Million)
 Table 42. US & Canada Sales by Application (2020-2031) & (K Units)
 Table 43. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 44. US & Canada Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 45. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 46. US & Canada Sales by Country (2020-2031) & (K Units)
 Table 47. Europe Sales by Distribution Channel (2020-2031) & (K Units)
 Table 48. Europe Revenue by Distribution Channel (2020-2031) & (US$ Million)
 Table 49. Europe Sales by Application (2020-2031) & (K Units)
 Table 50. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 51. Europe Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 52. Europe Sales by Country (2020-2031) & (K Units)
 Table 53. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 54. China Sales by Distribution Channel (2020-2031) & (K Units)
 Table 55. China Revenue by Distribution Channel (2020-2031) & (US$ Million)
 Table 56. China Sales by Application (2020-2031) & (K Units)
 Table 57. China Revenue by Application (2020-2031) & (US$ Million)
 Table 58. Asia Sales by Distribution Channel (2020-2031) & (K Units)
 Table 59. Asia Revenue by Distribution Channel (2020-2031) & (US$ Million)
 Table 60. Asia Sales by Application (2020-2031) & (K Units)
 Table 61. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 62. Asia Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 63. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 64. Asia Sales by Region (2020-2031) & (K Units)
 Table 65. Middle East, Africa and Latin America Sales by Distribution Channel (2020-2031) & (K Units)
 Table 66. Middle East, Africa and Latin America Revenue by Distribution Channel (2020-2031) & (US$ Million)
 Table 67. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)
 Table 68. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 69. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 70. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 71. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)
 Table 72. Sanofi Pasteur Company Information
 Table 73. Sanofi Pasteur Description and Major Businesses
 Table 74. Sanofi Pasteur Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Sanofi Pasteur Product Model Numbers, Pictures, Descriptions and Specifications
 Table 76. Sanofi Pasteur Recent Developments
 Table 77. Bio-Manguinhos Company Information
 Table 78. Bio-Manguinhos Description and Major Businesses
 Table 79. Bio-Manguinhos Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Bio-Manguinhos Product Model Numbers, Pictures, Descriptions and Specifications
 Table 81. Bio-Manguinhos Recent Developments
 Table 82. FSUE Chumakov Company Information
 Table 83. FSUE Chumakov Description and Major Businesses
 Table 84. FSUE Chumakov Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. FSUE Chumakov Product Model Numbers, Pictures, Descriptions and Specifications
 Table 86. FSUE Chumakov Recent Developments
 Table 87. Institut Pasteur de Dakar Company Information
 Table 88. Institut Pasteur de Dakar Description and Major Businesses
 Table 89. Institut Pasteur de Dakar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Institut Pasteur de Dakar Product Model Numbers, Pictures, Descriptions and Specifications
 Table 91. Institut Pasteur de Dakar Recent Developments
 Table 92. Key Raw Materials Lists
 Table 93. Raw Materials Key Suppliers Lists
 Table 94. Distributors List
 Table 95. Customers List
 Table 96. Market Trends
 Table 97. Market Drivers
 Table 98. Market Challenges
 Table 99. Market Restraints
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources


List of Figures
 Figure 1. Yellow Fever Vaccines Product Picture
 Figure 2. Global Yellow Fever Vaccines Market Size Growth Rate by Distribution Channel, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Yellow Fever Vaccines Market Share by Distribution Channel: 2024 & 2031
 Figure 4. Institonal Contributions Product Picture
 Figure 5. Private Purchase Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Yellow Fever Vaccines Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Global Yellow Fever Vaccines Market Share by Application: 2024 & 2031
 Figure 9. Routine Immunization
 Figure 10. Travelers
 Figure 11. Other
 Figure 12. Yellow Fever Vaccines Report Years Considered
 Figure 13. Global Yellow Fever Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Yellow Fever Vaccines Revenue by Region (2020-2031) (US$ Million)
 Figure 16. Global Yellow Fever Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 17. Global Yellow Fever Vaccines Revenue Market Share by Region (2020-2031)
 Figure 18. Global Yellow Fever Vaccines Sales (2020-2031) & (K Units)
 Figure 19. Global Yellow Fever Vaccines Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Figure 20. Global Yellow Fever Vaccines Sales Market Share by Region (2020-2031)
 Figure 21. US & Canada Yellow Fever Vaccines Sales YoY (2020-2031) & (K Units)
 Figure 22. US & Canada Yellow Fever Vaccines Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. Europe Yellow Fever Vaccines Sales YoY (2020-2031) & (K Units)
 Figure 24. Europe Yellow Fever Vaccines Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. China Yellow Fever Vaccines Sales YoY (2020-2031) & (K Units)
 Figure 26. China Yellow Fever Vaccines Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Asia (excluding China) Yellow Fever Vaccines Sales YoY (2020-2031) & (K Units)
 Figure 28. Asia (excluding China) Yellow Fever Vaccines Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Middle East, Africa and Latin America Yellow Fever Vaccines Sales YoY (2020-2031) & (K Units)
 Figure 30. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Global Yellow Fever Vaccines Sales Share by Manufacturers (2024)
 Figure 32. The Yellow Fever Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 33. Global Yellow Fever Vaccines Revenue Share by Manufacturers (2024)
 Figure 34. The Top 5 and 10 Largest Manufacturers of Yellow Fever Vaccines in the World: Market Share by Yellow Fever Vaccines Revenue in 2024
 Figure 35. Global Yellow Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 36. Global Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2031)
 Figure 37. Global Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2020-2031)
 Figure 38. Global Yellow Fever Vaccines Sales Market Share by Application (2020-2031)
 Figure 39. Global Yellow Fever Vaccines Revenue Market Share by Application (2020-2031)
 Figure 40. US & Canada Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2031)
 Figure 41. US & Canada Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2020-2031)
 Figure 42. US & Canada Yellow Fever Vaccines Sales Market Share by Application (2020-2031)
 Figure 43. US & Canada Yellow Fever Vaccines Revenue Market Share by Application (2020-2031)
 Figure 44. US & Canada Yellow Fever Vaccines Revenue Share by Country (2020-2031)
 Figure 45. US & Canada Yellow Fever Vaccines Sales Share by Country (2020-2031)
 Figure 46. US Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 47. Canada Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 48. Europe Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2031)
 Figure 49. Europe Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2020-2031)
 Figure 50. Europe Yellow Fever Vaccines Sales Market Share by Application (2020-2031)
 Figure 51. Europe Yellow Fever Vaccines Revenue Market Share by Application (2020-2031)
 Figure 52. Europe Yellow Fever Vaccines Sales Share by Country (2020-2031)
 Figure 53. Europe Yellow Fever Vaccines Revenue Share by Country (2020-2031)
 Figure 54. Germany Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 55. France Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 59. China Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2031)
 Figure 60. China Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2020-2031)
 Figure 61. China Yellow Fever Vaccines Sales Market Share by Application (2020-2031)
 Figure 62. China Yellow Fever Vaccines Revenue Market Share by Application (2020-2031)
 Figure 63. Asia Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2031)
 Figure 64. Asia Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2020-2031)
 Figure 65. Asia Yellow Fever Vaccines Sales Market Share by Application (2020-2031)
 Figure 66. Asia Yellow Fever Vaccines Revenue Market Share by Application (2020-2031)
 Figure 67. Asia Yellow Fever Vaccines Revenue Share by Region (2020-2031)
 Figure 68. Asia Yellow Fever Vaccines Sales Share by Region (2020-2031)
 Figure 69. Japan Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 70. South Korea Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 71. China Taiwan Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 72. Southeast Asia Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 73. India Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 74. Australia Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 75. Middle East, Africa and Latin America Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2031)
 Figure 76. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2020-2031)
 Figure 77. Middle East, Africa and Latin America Yellow Fever Vaccines Sales Market Share by Application (2020-2031)
 Figure 78. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Market Share by Application (2020-2031)
 Figure 79. Middle East, Africa and Latin America Yellow Fever Vaccines Revenue Share by Country (2020-2031)
 Figure 80. Middle East, Africa and Latin America Yellow Fever Vaccines Sales Share by Country (2020-2031)
 Figure 81. Brazil Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 82. Mexico Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 83. Turkey Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 84. Israel Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 85. GCC Countries Yellow Fever Vaccines Revenue (2020-2031) & (US$ Million)
 Figure 86. Value Chain
 Figure 87. Yellow Fever Vaccines Production Process
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed